{"id":804057,"date":"2026-03-17T01:48:12","date_gmt":"2026-03-17T01:48:12","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/804057\/"},"modified":"2026-03-17T01:48:12","modified_gmt":"2026-03-17T01:48:12","slug":"covid-19-la-securite-des-vaccins-a-arn-messager-confirmee-apres-cinq-ans-denquete","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/804057\/","title":{"rendered":"Covid-19 : La s\u00e9curit\u00e9 des vaccins \u00e0 ARN messager confirm\u00e9e apr\u00e8s cinq ans d\u2019enqu\u00eate"},"content":{"rendered":"

L\u2019Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament (ANSM) a annonc\u00e9, lundi, la fin de son enqu\u00eate nationale de pharmacovigilance sur les vaccins anti-Covid \u00e0 ARN messager<\/a>, apr\u00e8s cinq ann\u00e9es de suivi renforc\u00e9. L\u2019autorit\u00e9 sanitaire pr\u00e9cise toutefois que la surveillance ne s\u2019arr\u00eate pas : les signalements continueront d\u2019\u00eatre analys\u00e9s par les centres r\u00e9gionaux de pharmacovigilance. Les donn\u00e9es les plus r\u00e9centes concernant les vaccins Comirnaty (Pfizer-BioNTech<\/a>) et Spikevax (Moderna<\/a>) \u00ab confirment une nouvelle fois que ces vaccins sont s\u00fbrs \u00bb, selon l\u2019agence.<\/p>\n

Les deux rapports couvrant la p\u00e9riode de f\u00e9vrier 2024 \u00e0 juin 2025 n\u2019ont identifi\u00e9 aucun nouveau signal de s\u00e9curit\u00e9. Pour Comirnaty, l\u2019analyse de 21 cas d\u2019effets ind\u00e9sirables potentiels jug\u00e9s \u00ab marquants \u00bb n\u2019a montr\u00e9 qu\u2019\u00ab aucun lien avec la vaccination<\/a> n\u2019a \u00e9t\u00e9 \u00e9tabli \u00bb. Les investigations ont notamment concern\u00e9 des cas d\u2019occlusion de la veine centrale r\u00e9tinienne, d\u2019uv\u00e9ite, de syndrome de tachycardie orthostatique posturale, d\u2019enc\u00e9phalomy\u00e9lite myalgique, de syndrome de fatigue chronique, de HELLP syndrome ou encore de scl\u00e9rose lat\u00e9rale amyotrophique (SLA).<\/p>\n

Pas de hausse de mortalit\u00e9 en France<\/p>\n

Des conclusions similaires ressortent pour Spikevax. L\u2019\u00e9tude de cinq cas marquants n\u2019a pas permis d\u2019associer la vaccination aux pathologies observ\u00e9es, qu\u2019il s\u2019agisse de deux cas de SLA, d\u2019un cas de dermatomyosite ou de signalements de syndrome de fatigue chronique. L\u2019ANSM souligne qu\u2019apr\u00e8s cinq ans de suivi, elle dispose d\u00e9sormais \u00ab d\u2019un recul san(…)<\/p>\n

Lire la suite sur 20minutes<\/a><\/p>\n

\u00c0 lire aussi :
Covid-19 : Cancer, VIH, bronchiolite\u2026 \u00ab L\u2019arsenal des vaccins \u00e0 ARN messager est en pleine expansion \u00bb <\/a>
Les Etats-Unis annulent leur financement de plusieurs vaccins \u00e0 ARN messager<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"L\u2019Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament (ANSM) a annonc\u00e9, lundi, la fin de son enqu\u00eate nationale de pharmacovigilance…\n","protected":false},"author":2,"featured_media":804058,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[10],"tags":[56266,61008,1011,27,72,71,656,88166,88167],"class_list":["post-804057","post","type-post","status-publish","format-standard","has-post-thumbnail","category-sante","tag-ansm","tag-arn-messager","tag-fr","tag-france","tag-health","tag-sante","tag-securite","tag-syndrome-de-fatigue-chronique","tag-vaccins-comirnaty"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/116242003264376333","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/804057","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=804057"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/804057\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/804058"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=804057"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=804057"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=804057"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}